HUP0003922A3 - Use of thiazolidinediones for the treatment of hyperglycaemia - Google Patents

Use of thiazolidinediones for the treatment of hyperglycaemia

Info

Publication number
HUP0003922A3
HUP0003922A3 HU0003922A HUP0003922A HUP0003922A3 HU P0003922 A3 HUP0003922 A3 HU P0003922A3 HU 0003922 A HU0003922 A HU 0003922A HU P0003922 A HUP0003922 A HU P0003922A HU P0003922 A3 HUP0003922 A3 HU P0003922A3
Authority
HU
Hungary
Prior art keywords
hyperglycaemia
thiazolidinediones
treatment
Prior art date
Application number
HU0003922A
Other languages
English (en)
Hungarian (hu)
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of HUP0003922A2 publication Critical patent/HUP0003922A2/hu
Publication of HUP0003922A3 publication Critical patent/HUP0003922A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
HU0003922A 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia HUP0003922A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9721693.1A GB9721693D0 (en) 1997-10-13 1997-10-13 Novel treatment
PCT/GB1998/003064 WO1999018943A1 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Publications (2)

Publication Number Publication Date
HUP0003922A2 HUP0003922A2 (hu) 2001-10-28
HUP0003922A3 true HUP0003922A3 (en) 2001-12-28

Family

ID=10820482

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0003922A HUP0003922A3 (en) 1997-10-13 1998-10-12 Use of thiazolidinediones for the treatment of hyperglycaemia

Country Status (24)

Country Link
EP (1) EP1023056A1 (xx)
JP (1) JP2001519382A (xx)
KR (1) KR20010024481A (xx)
CN (1) CN1281359A (xx)
AP (1) AP2000001787A0 (xx)
AU (1) AU9547098A (xx)
BG (1) BG104404A (xx)
BR (1) BR9815219A (xx)
CA (1) CA2306086A1 (xx)
CZ (1) CZ20001297A3 (xx)
EA (1) EA002659B1 (xx)
GB (1) GB9721693D0 (xx)
HR (1) HRP20000255A2 (xx)
HU (1) HUP0003922A3 (xx)
ID (1) ID24521A (xx)
IL (1) IL135513A0 (xx)
NO (1) NO20001898L (xx)
NZ (1) NZ503862A (xx)
OA (1) OA11683A (xx)
PL (1) PL339813A1 (xx)
SK (1) SK5312000A3 (xx)
TR (1) TR200000958T2 (xx)
WO (1) WO1999018943A1 (xx)
YU (1) YU28800A (xx)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
US5457109A (en) * 1993-09-15 1995-10-10 Warner-Lambert Company Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of disease states at risk for progressing to noninsulin-dependent diabetes mellitus

Also Published As

Publication number Publication date
BR9815219A (pt) 2001-01-02
JP2001519382A (ja) 2001-10-23
IL135513A0 (en) 2001-05-20
OA11683A (en) 2005-01-12
AU9547098A (en) 1999-05-03
CN1281359A (zh) 2001-01-24
AP2000001787A0 (en) 2000-06-30
GB9721693D0 (en) 1997-12-10
WO1999018943A1 (en) 1999-04-22
EA200000419A1 (ru) 2000-10-30
CA2306086A1 (en) 1999-04-22
BG104404A (bg) 2000-12-29
YU28800A (sh) 2003-02-28
CZ20001297A3 (cs) 2001-08-15
KR20010024481A (ko) 2001-03-26
NZ503862A (en) 2003-01-31
EP1023056A1 (en) 2000-08-02
PL339813A1 (en) 2001-01-02
NO20001898L (no) 2000-06-09
TR200000958T2 (tr) 2000-08-21
ID24521A (id) 2000-07-20
EA002659B1 (ru) 2002-08-29
SK5312000A3 (en) 2000-09-12
NO20001898D0 (no) 2000-04-12
HUP0003922A2 (hu) 2001-10-28
HRP20000255A2 (en) 2001-02-28

Similar Documents

Publication Publication Date Title
GB2321719B (en) Liquid treatment
EP0703282A3 (en) Surface treatment composition
HUP0002030A3 (en) Use of glur5 receptorantagonists for the treatment of pain
AU1542895A (en) Surface treatment
AU4774597A (en) Use of 1-hydroxy-2-pyridones for the treatment of skin infections
AU7310896A (en) Use of nitroflavonoids for the treatment of anxiety
AU3124295A (en) Surface treatment techniques
EP0860867A4 (en) SURFACE TREATMENT FOR MICRO-MACHINING
GB9511214D0 (en) Surface treatment
EP0755255A4 (en) TREATMENT OF TOXOPLASMOSIS
GB2304286B (en) Biocidal hard surface treatment
IL130831A0 (en) Imino-aza-anthracylinone derivatives for the treatment of amyloidosis
IL123530A0 (en) Procedure for the surface treatment of petrous materials
GB2355006B (en) Materials treatment
IL135515A0 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
GB9416410D0 (en) Effluent treatment
GB9726223D0 (en) The treatment of materials
HUP0003922A3 (en) Use of thiazolidinediones for the treatment of hyperglycaemia
AUPO458197A0 (en) Synthetic surface treatment apparatus
GB2331514B (en) Effluent treatment
GB9611315D0 (en) Treatment of painted surfaces
AU5203898A (en) Synthetic surface treatment apparatus
GB9605961D0 (en) Surface treatment
GB9615469D0 (en) Surface treatment
GB9402103D0 (en) Surface treatment

Legal Events

Date Code Title Description
FA9A Lapse of provisional patent protection due to relinquishment or protection considered relinquished